Wedbush Keeps Their Buy Rating on Neurocrine (NBIX)
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Neurocrine (NBIX – Research Report), with a price target of ...
Wedbush Sticks to Its Buy Rating for AnaptysBio (ANAB)
Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...
Pinterest Stock Soars as Revenue, Users Beat Expectations
Pinterest stock is higher Friday after the social media site beat revenue and user expectations for its fourth quarter.
Amazon Is the Worst Dow Stock After Earnings. Here's Why
Amazon stock is at the bottom of the Dow Friday as the e-commerce giant's soft outlook offsets a fourth-quarter beat. This is ...